180915-95-1Relevant articles and documents
A PROCESS FOR THE PREPARATION OF LASOFOXIFENE TARTRATE
-
Page/Page column 20, (2010/11/17)
The present invention relates to solid state chemistry of 1-(2-[4-(6-methoxy-3,4-dihydronaphthalene-1-yl) phenoxy]ethyl)pyrrolidine, a process for its preparation and its use as an intermediate in the synthesis of lasofoxifene.
Pharmaceutical composition having uniform drug distribution and potency
-
, (2008/06/13)
Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient and containing a silicon dioxide to reduce loss of the active ingredient during the manufacturing process and methods for manufacturing such compositions are disclosed.
Estrogen agonists/antagonists
-
, (2008/06/13)
Compounds of this formula are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.